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This study contributes to the investigation related to guest–host interactions between the chemotherapeutic agent cisplatin
and a functionalised silica matrix in order to improve and find new materials such as drug carriers. The adsorption of
cisplatin and its complexes, cis-[PtCl(NH3)2]
þ and cis-[Pt(NH3)2]
2þ, on a SH-functionalised SiO2(111) surface has been
studied by the atom superposition and electron delocalisation method. The adiabatic energy curves for the adsorption of the
drug and its products on the delivery system were considered. The electronic structure and bonding analysis were also
performed. The molecule and their complex are adsorbed on the functionalised surface resulting in a major absorption of the
cis-[Pt(NH3)2]
2þ complex. The molecule–surface interactions are formed via ZSH group. The molecule/complexes SH
electron-donating effect plays an important role in the catalytic reaction. The more important drug–carrier interactions
occur through the ClZH bond for the adsorption of cis-[PtCl2(NH3)2] and cis-[PtCl(NH3)2]
þ, and through the PtZS and
PtZH interactions for cis-[Pt(NH3)2]
2þ adsorption. When the new interactions are formed, the functionalised carrier
maintains their matrix properties while the molecule is the most affected after adsorption. The Pt atomic orbitals present the
most important changes during adsorption.
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1. Introduction
The recent emergence of the periodic mesoporous
materials becomes an active area of research because of
their exciting potential applications in catalysis, separ-
ation, drug delivery, nanocomposites and confinement of
electronic materials. Each mesoporous material has its
own typical features that differ from those of others, such
as mesostructure, pore size, surface area and pore volume.
In the practical reaction, their characteristics could have a
great effect on the results of catalytic behaviour, such as
activity, selectivity and product yield.
Functional groups can increase the adsorption perform-
ance of mesoporous silica [1]. Different types of
immobilisation ofmetal complexes were performed through
a coordination bond with functional groups on the
mesoporous supports. There have been dramatic develop-
ments in the studies on surface functionalisation of
mesoporous materials [2–5]. For the functionalisation,
aliphatic hydrocarbon [6], phenyl [7], amine [8] and vinyl,
benzyl, phenyl, cyano, mercapto, aminopropyl or dihydroi-
midazole [9] ligands have been mainly studied as surface
functional groups.
Functionalised mesoporous materials for adsorption
and release of different drug molecules have been studied
by Wang et al. The different functional groups introduced
into the materials dictated their adsorption capacity
and release properties. While mercaptopropyl- and vinyl-
functionalised samples showed high adsorption capacity
for rhodamine 6G, amine-functionalised samples exhib-
ited higher adsorption capacity for ibuprofen [10].
Luminescent organic–inorganic hybrids of functiona-Q2
lised mesoporous silica have been investigated by Li et al.
using thio-salicylidene schiff base. The synthesis of
bis(salicylidene)-thiocarbohydrazide (BSTC-SBA-15)
provides a convenient approach of tailoring the surface
properties of mesoporous silicates by organic functiona-
lisation, and all the resulting materials retain the ordered
mesoporous structures [11].
A recyclable thiol-functionalised mesoporous silica for
detection and removal of Cu(II) ions has been studied by
Li et al. The adsorption capacity of the recycled silicas
remains the same as that of the freshly prepared, which
makes them promising adsorbents for wastewater cleanup
[12].
Sulphonic-functionalised mesoporous materials
received exceptional attention because of their numerous
practical applications in heterogeneous acid catalysis,
toxic mercury ion trapping, biomolecule immobilisation
and as a support material for metallic nanoparticles [13].
Many of the current chemotherapeutic drugs cause
severe toxicity to the body, such as hair loss and nausea,
when administered at high systemic doses. The optimis-
ation of the dosing through delivery systems can
potentially minimise the adverse effects while maintaining
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efficacy. The objective of this project is to study the
adsorption properties of thiol-functionalised porous silica
as vehicles for the local and sustained delivery of the
chemotherapeutic agent: cisplatin. Cisplatin (cis-diamine-
dichloroplatinum [II]) is a coordination compound used in
the treatment of several solid tumours [14,15]. It is a well-
known square planar complex with chemical formula cis-
[Pt(NH3)2Cl2], first described by Michel Peyrone in 1844.
The structure was elucidated by Alfred Werner nearly 50
years later in 1893. Aiming to predict potentially active
species in the mode of action of the anticancer drug
cisplatin, the study focused on the hydrolysis of one or
both platinum-chloro bonds of the drug [16,17] also on the
functionalised matrix. The energy curves for the adsorp-
tion of cisplatin and its complexes on the thiol-
functionalised silica are calculated by the atom super-
position and electron delocalisation (ASED) method. The
electronic structure and the chemical bonding after
adsorption are also addressed.
2. Computational method
Our calculations were performed using the ASED method
[18–21]. This method is a modification of the extended
Hückel molecular orbital method implemented with the
yet another extended Hückel molecular orbital package
program [22]. The ASED theory is based on a physical
model of molecular and solid electronic charge density
distribution functions [21–24].
The adiabatic total energy values were computed as the
difference between the electronic energy (E) of the system
when the drug is at finite distance on the functionalised
surface (carrier) and the same energy when it is far away
from the surface:
DEAbs; total ¼ E ðcarrierþ drugÞ2 E ðcarrierÞ2 E ðdrugÞ:
The repulsive energy was computed taking into
account all atom–atom interactions.
To understand the drug–carrier interactions, we used
the concept of density of states (DOS) and crystal orbital
overlap population (COOP) curves. TheDOS curve is a plot
of the number of orbitals per unit volume per unit energy.
The COOP curve is a plot of the overlap population (OP)-
weighted DOS versus energy. The integration of the COOP
curve up to the Fermi level (Ef) gives the total OP of the
bond specified, and it is a measure of the bond strength.
3. The drug–carrier system
A silicon dioxide-hydrated matrix was performed to
simulate the solid carrier according De Boer et al.’s [25]
model. The original cluster has 209 atoms (27 hydrogens,
128 oxygens and 54 silicons). The cluster was functiona-
lised by introducing SH silane groups stream replacing
50% of the hydroxyl groups of the surface. The starting
point for the calculation is the cisplatin structure taken
from the experimental data [26,27]. During the calcu-
lations, the structures of both molecule and substrate were
optimised at steps of 0.02 Å and convergence in energy by
0.01 eV. Different molecule/fragments orientations and
adsorption sites on the functionalised silica surface were
taken in order to obtain the optimum adsorption geometry
and the preferential adsorption site. The most favourable
corresponds to the vertical adsorption of the molecule, and
its fragments in a way that the Cl atoms are closer to the
SH groups of the silica surface. Figure 1 shows a
schematic representation of cisplatin/complexes silica
adsorption geometry. We have computed the adiabatic
energy of the system by absorbing the drug on the
SiO2(111)-functionalised surface. We have obtained theQ3
energy curves, initially for the cisplatin molecule and then,
considering the removal of one and the two chloro atoms
of the molecule, in order to analyse the hydrolysis products
adsorption. Then, we have studied the major electronic
interactions between the drug/fragments and the thiol-
functionalised silica surface.
4. Results and discussion
The adsorption energies for cisplatin and its complexes are
shown in Figure 2. For cis-[PtCl2(NH3)2] adsorption, the
system becomes more stable considering the SHZCl
distances above 3.2 Å, showing a weak molecule–surface
absorption (see Figure 1(a)).We can see the inexistence of a
minimum energy position. For the [PtCl(NH3)2]
þ complex,
we can see in Figure 1(b) that the system is more stable
when this complex is from 2.6 Å on the surface and again
the adsorption is weak without a minimum energy location
for the complex. In opposition, for the cis-[Pt(NH3)2]
2þ
adsorption, the system is most stable when the complex is
0.2 Å to the surface and now the existence of a minimum
energy position for the complex is evident (see Figure 1(c)).
Considering the hoped balance between the cisplatin and its
products [6–8] and analysing the energy curves (Figure 1),
we can conclude that the molecule and their complex can
adsorb on the functionalised surface resulting in a major
absorption of the cis-[Pt(NH3)2]
2þ complex.
Figure 2(a) shows the DOS curve for the cis-
[PtCl2(NH3)2]–silica system. Ifwecompare the correspond-Q2
ing isolated functionalised silica with Figure 2(b), the
changes are small because the presence of molecule is
almost negligible. The contributions to the DOS of the
cisplatin orbitals are evident if those are magnified by a
factor of 100 in Figure 2(c). The horizontal sticks display the
energy of the molecular orbitals in the isolated cisplatin.
We can see the bands’ dispersion due to the interaction with
the functionalised silica surface. After adsorption, the bands
are spread over and a portion of its DOS is pushed above the
GMOS 690875—16/5/2012—ANANDAN.R—418109———Style 3























Fermi level. The value of the Fermi energy (Ef) of the cis-
[PtCl2(NH3)2]–silica system is 211.56 eV and it changes
slightlywith respect to the isolated silica (Ef ¼ 212.52 eV).
The states below the Fermi level mainly correspond to the
silicon conduction band.
According to the most favourable adsorption energy
ranges for the molecule and their complexes, we have
selected one configuration of each sub-system in order to
perform the electronic structure analysis and bonding
considerations.
For cis-[PtCl2(NH3)2]–silica system, we have selected
the geometry corresponding to the molecule–surface
distance (ClZH distance) of 3.2 Å. For this configuration,
each Cl atoms to the cisplatin have very small interactions
with the H atoms of two nearest-neighbour SH groups of
the functionalised surface. The existence of these bonds isQ3
confirmed by the bond population, the ClZH OPs are both
0.0006. The COOP curve is shown in Figure 3(a). This
curve presents bonding and anti-bonding peaks below the
Fermi energy level (Ef). The integration up to the Fermi
level gives the total OP for the ClZH bonding. On the
other hand, the ClZSi interactions are almost negligible
and there is no evidence for ClZS and ClZO interactions.
Figure 2. (a) Total DOS for the cisplatin/silica–SH system, (b)
total DOS for the isolated silica–SH system and (c) projected
DOS for the cisplatin molecule adsorbed on the silica–SH
surface. The horizontal solid lines indicate the orbital positions in

















Figure 1. Adiabatic energy curves for the (a) cisplatin/silica–SH system, (b) cis-[PtCl(NH3)2]
þ/silica–SH system and (c) cis-
[Pt(NH3)2]


























þ–silica system, we have selected
the geometry corresponding to the complex located at
2.6 Å to the surface. For this configuration, the Cl atom has
an interaction with an H atom of a SH group of the surface.
The ClZH bond population is 0.0032. The interaction isQ2
small but bigger than the ClZH interaction as described
previously; the COOP curve is shown in Figure 3(b). A
very little ClZSi interaction is observed and no evidence
for ClZS and ClZO interactions is noticed.
For cis-[Pt(NH3)2]
2þ–silica system, we have con-
sidered the geometry corresponding to the complex
located at the minimum energy position of 0.2 Å to the
surface. When the two chloro atoms are removed, the most
favourable interactions occur between the Pt and both S
and H atoms of neigbouring SH groups. The PtZS and
PtZH OP values are 0.0026 and 0.0017, respectively;
Figure 3(c) and (d) shows the COOP curves that mainly
correspond to a bonding interactions. On the other hand,
the PtZSi interaction is not evident.
The adsorption of the drug is possible because it
produced a rearrangement of the electronic densities of the
solid-functionalised surface and the cisplatin atomic
orbitals. The major changes are summarised in Table 1.
For cis-[PtCl2(NH3)2]–silica system, the OPs of the SQ3
and H atoms of the surface modified less than 0.02%, the
major changes are observed in S px and H s orbitals; while
the Cl s and Cl p orbitals of the molecule decrease 0.4% and
20%, respectively, themost important changes are presented
in Cl py and Cl pz orbitals. The s, p and d OPs of the Pt atomQ2
are decreased by 32%, 5%, and 85%, respectively; the
bigger changes are observed in Pt s, d2z 2 d
2
y , dxy and dyz
orbitals. Then, for cis-[PtCl2(NH3)2]–silica interaction, the
most affected are the Cl p, Pt s and Pt d OPs.
For cis-[PtCl(NH3)2]
þ–silica system, theH s populationQ2
of SH superficial group are decreased by 0.3%, whereas the
corresponding s and p OPs of the S atom are increased by
less than 0.2%. The s and pOPs of the Cl atom are decreasedQ2
by 0.3% and 6%, respectively, themajor change is present in
Cl py orbital; whereas the s, p, and d OPs of the Pt atom are
decreased by 32%, 26% and 88%, respectively, the bigger
changes are observed in Pt d2z and dyz orbitals. Therefore, the
Pt atomic orbitals of the cis-[PtCl(NH3)2]
þ complex are the
most affected after adsorption.
For cis-[Pt(NH3)2]
2þ–silica system, the H s populationQ2
of SH group is decreased by 0.03%, whereas the
corresponding s and p OPs of the S atom are decreased in a
lesser amount. The s, p and d OPs of the Pt atom are
decreased by 48%, 67%, and 93%, respectively, the major




y , dxy and dyzorbitals.
Consequently, for cis-[Pt(NH3)2]
2þ adsorption, the major
changes are produced in Pt OPs.
Q2
In general, it can be observed that after adsorption the
molecule presents bigger changes than the functionalised
surface.
The electron exchange helps to form the absorbate–
substrate interactions. For cis-[PtCl2(NH3)2]–silica system, itQ3
is observed that an electron transfer to the Pt, Cl, and H atoms
to the S atom. For cis-[PtCl(NH3)2]
þ–silica system, it isQ3
observed that an electron transfer to the Pt and H atoms to the
Cl andS atoms;while forcis-[Pt(NH3)2]
2þ–silica system, it is
observed that anelectron transfer to thePt andHatoms to theS
atoms.
Figure 3. COOP curves for (a) the ClZH interaction in the
cisplatin/silica–SH system, (b) the ClZH interaction in the cis-
[PtCl(NH3)2]
þ/silica–SH system, (c) PtZH and (d) PtZS
interactions in the cis-[Pt(NH3)2 ]2þ/silica–SH system.
Table 1. Orbital occupations, net charges and OP for the atoms
which participate in the interactions.
Orbital occupation







































2þ/silica–SH system. d Isolated silica–SH or
isolated cisplatin.
GMOS 690875—16/5/2012—ANANDAN.R—418109———Style 3























In general, when the new interactions are formed, the
strength of the SH bond practically is not affected after
adsorption (less than 0.5%, see Table 1). In opposite, in the
molecule, the ClZPt interaction is affected after adsorp-
tion. The CZPt OP in the isolated molecule is 0.5345 and
increases to 0.7190 (26%) and 0.9155 (42%) during the
adsorption of cis-[PtCl2(NH3)2] and cis-[PtCl(NH3)2]
þ,
respectively. We can conclude that the carrier matrix
maintains their properties after adsorption, and the ClZPt




This paper contributes to the investigation in relation to
guest–host interactions between cisplatin and a SH-
functionalised silica matrix in order to improve and find
new materials such as drug carriers.
The adsorption of cisplatin on a SH-functionalised
SiO2(111) surface was investigated by tight binding
calculation. We were able to evaluate the simultaneous
manifestation of true confinement and surface effects in this
silica host for a drug. Starting from the optimisation of the
adsorption geometries for the drug and its complexes, we
could reproduce the main characteristics of the adsorption
process. We have also analysed the nature of the drug–
carrier bonding and the changes observed in the electronic
structure upon adsorption.
The silica–SH carrier showed catalytic properties.
Except those molecular orbitals lying much lower in energy,
the rest are modified showing the molecule–surface
interaction. From the energy plots, the molecule and their
complex are adsorbed on the functionalised surface resulting
in a major absorption of the therapeutic cis-[Pt(NH3)2]
2þ
complex.
We have computed the new bondings by the OP and
COOP curves. The new interactions are formed via the SH
groups. It was found that the molecule/complex SH
electron-donating effect plays an important role in the
catalytic reaction. The drug–carrier interactions occur
through the ClZH interaction for the adsorption of cis-
[PtCl2(NH3)2] and cis-[PtCl(NH3)2]
þ, and through PtZS
and PtZH interactions for cis-[Pt(NH3)2]
2þ adsorption.
When the new interactions are formed, the functionalised
carriermaintains their matrix properties while themolecule
is the most affected after adsorption, the major changes are
produced in Pt atomic orbitals.
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